Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 9Hematopoietic and Lymphatic System Neoplasm 5Hematopoietic and Lymphoid System Neoplasm 4Malignant Solid Neoplasm 3Unspecified Childhood Solid Tumor, Protocol Specific 2Advanced Malignant Solid Neoplasm 2Thymoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Mesothelioma, Malignant 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2Celecoxib 2pembrolizumab 1olaparib 1fludarabine 1entinostat 1bosutinib 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Pemetrexed 1Leucovorin 1Imatinib Mesylate 1Fentanyl 1FANG vaccine 1Early Intervention, Educational 1Doxepin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Early Intervention, Educational × Other solid neoplasm × Clear all
NCT00372840 2020-03-02

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Fox Chase Cancer Center

Phase NA Completed
340 enrolled
BreastGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Thymoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡